Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis

INTRODUCTION: The aim of this study was to evaluate the efficacy and safety of ultra-rapid lispro (URLi) versus lispro in a subgroup analysis of Japanese adults with type 2 diabetes mellitus (T2DM) from the phase 3 PRONTO-T2D trial. METHODS: After an 8-week lead-in period during which patients trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinnouchi, Hideaki, Imori, Makoto, Nishiyama, Hiroshi, Imaoka, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434814/
https://www.ncbi.nlm.nih.gov/pubmed/32728833
http://dx.doi.org/10.1007/s13300-020-00890-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434814/
https://www.ncbi.nlm.nih.gov/pubmed/32728833
http://dx.doi.org/10.1007/s13300-020-00890-2

Ejemplares similares